DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis

Trial Profile

DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Jun 2017

At a glance

  • Drugs DMT 200 (Primary)
  • Indications Atopic dermatitis
  • Focus Therapeutic Use
  • Sponsors Dermata Therapeutics
  • Most Recent Events

    • 07 Jun 2017 Planned End Date changed from 1 Mar 2017 to 1 Aug 2017.
    • 07 Jun 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Aug 2017.
    • 07 Jun 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top